BiomX Inc. (NYSE American: PHGE) has announced an amendment to the terms of its existing warrant agreement, originally established in December 2025. The amendment, effective March 13, 2026, modifies the expiration date of the warrant from five years to December 31, 2026, and reduces the exercise price from $2.00 to $1.00 per share. This strategic move aims to enhance the company's financial flexibility and streamline its capital structure, allowing for a more disciplined approach to future investments and operational execution. The decision to amend the warrant terms was made in collaboration with the warrant holders and reflects the company's commitment to stabilizing its financial footing amidst ongoing market challenges. The amendment is expected to alleviate potential overhangs associated with long-dated warrants, thereby improving investor sentiment and potentially enhancing the company's market valuation. BiomX's leadership has emphasized the importance of these changes in positioning the company for future growth opportunities, particularly in sectors with strong global demand for advanced technologies. The company is actively evaluating strategic opportunities and engaging with capital markets to support its long-term objectives.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.